Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taipei Exchange - Delayed Quote TWD

LAUNXP Biomedical Co., Ltd (6876.TWO)

18.10
+1.10
+(6.47%)
At close: 2:59:59 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,484
2,484
11
--
--
Cost of Revenue
199
199
--
--
--
Gross Profit
2,285
2,285
11
--
--
Operating Expense
84,589
84,589
81,060
43,620
34,828
Operating Income
-82,304
-82,304
-81,049
-43,620
-34,828
Net Non Operating Interest Income Expense
872
872
199
-68
80
Pretax Income
-82,091
-82,091
-80,949
-43,612
-34,747
Tax Provision
504
504
--
--
--
Net Income Common Stockholders
-82,595
-82,595
-80,949
-43,612
-34,747
Diluted NI Available to Com Stockholders
-82,595
-82,595
-80,949
-43,612
-34,747
Basic EPS
-2.56
--
-3.44
-2.42
-2.06
Diluted EPS
-2.56
--
-3.44
-2.42
-2.06
Basic Average Shares
32,263.67
--
23,531.69
18,021.49
16,867.48
Diluted Average Shares
32,263.67
--
23,531.69
18,021.49
16,867.48
Rent Expense Supplemental
--
--
--
25
34
Total Expenses
84,788
84,788
81,060
43,620
34,828
Net Income from Continuing & Discontinued Operation
-82,595
-82,595
-80,949
-43,612
-34,747
Normalized Income
-82,595
-82,595
-80,949
-43,612
-34,747
Interest Income
914
914
366
127
140
Interest Expense
42
42
167
195
60
Net Interest Income
872
872
199
-68
80
EBIT
-82,049
-82,049
-80,782
-43,417
-34,687
EBITDA
-79,648
-79,648
-78,368
-41,067
-33,081
Reconciled Cost of Revenue
199
199
--
--
--
Reconciled Depreciation
2,401
2,401
2,414
2,350
1,605
Net Income from Continuing Operation Net Minority Interest
-82,595
-82,595
-80,949
-43,612
-34,747
Normalized EBITDA
-79,648
-79,648
-78,368
-41,067
-33,081
Tax Rate for Calcs
0
0
--
--
--
12/31/2021 - 1/18/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers